AspenBio Pharma, Inc.
Class Period: Feb 22, 2007 to Jul 19, 2010
Lead Plaintiff Deadline: Nov 30, 2010 + Deadline passed
Summary of Case:
A securities class action has been filed against AspenBio Pharma, Inc. (APPY) ("AspenBio" or the "Company") on behalf of all securities purchasers from February 22, 2007 through July 19, 2010, inclusive ("Class Period"), in the United States District Court for the Central District of California.
The complaint asserts violations of the federal securities laws against AspenBio and certain of its officers and directors for issuing materially false and misleading statements about the effectiveness of AppyScore as a test to diagnose appendicitis. According to the Complaint, Defendants were aware or recklessly disregarded information that AppyScore was not effective in detecting appendicitis as it could not differentiate between appendicitis and other medical conditions. The complaint alleges that this adverse information caused the Company's stock to drop, causing investors substantial losses.
If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.